Plasmodium malaria and antimalarial antibodies in the first year of life

Plasmodium falciparumProtein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya

(2015) Arlene E. Dent et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

Determinants of Infant Susceptibility to Malaria During the First Year of Life in South Western Cameroon

(2015) T. O. Apinjoh et al.   Open Forum Infectious Diseases

Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates

(2014) Jo-Anne Chan et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response

(2014) Danielle I. Stanisic et al.   INFECTION AND IMMUNITY

Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique

(2014) Augusto J Nhabomba et al.   MALARIA JOURNAL

The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research

(2014) Joseph D. Smith   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

New antigens for a multicomponent blood-stage malaria vaccine

(2014) F. H. Osier et al.   Science Translational Medicine

Transplacentally transferred functional antibodies against Plasmodium falciparum decrease with age

(2013) Patrick T. Wilson et al.   ACTA TROPICA

Identification and Prioritization of Merozoite Antigens as Targets of Protective Human Immunity to Plasmodium falciparum Malaria for Vaccine and Biomarker Development

(2013) J. S. Richards et al.   JOURNAL OF IMMUNOLOGY

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01

(2013) Nekoye Otsyula et al.   MALARIA JOURNAL

Severe malaria is associated with parasite binding to endothelial protein C receptor

(2013) Louise Turner et al.   NATURE

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria

(2013) Linda M. Murungi et al.   VACCINE

Placental Malaria is Associated With Increased Risk of Nonmalaria Infection During the First 18 Months of Life in a Beninese Population

(2012) A. Rachas et al.   CLINICAL INFECTIOUS DISEASES

Targets of antibodies against Plasmodium falciparum–infected erythrocytes in malaria immunity

(2012) Jo-Anne Chan et al.   JOURNAL OF CLINICAL INVESTIGATION

Impact of Malaria at the End of Pregnancy on Infant Mortality and Morbidity

(2011) Azucena Bardají et al.   JOURNAL OF INFECTIOUS DISEASES

Association between Naturally Acquired Antibodies to Erythrocyte‐Binding Antigens ofPlasmodium falciparumand Protection from Malaria and High‐Density Parasitemia

(2010) Jack S. Richards et al.   CLINICAL INFECTIOUS DISEASES

The role ofPlasmodium falciparumvariant surface antigens in protective immunity and vaccine development

(2010) Lars Hviid   Human vaccines & immunotherapeutics

IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine

(2010) Diana Quelhas et al.   IMMUNOBIOLOGY

Congenital and neonatal malaria in a rural Kenyan district hospital: An eight-year analysis

(2010) Michael K Mwaniki et al.   MALARIA JOURNAL

Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report

(2010) Veronica Del Punta et al.   MALARIA JOURNAL

Placental malaria, maternal HIV infection and infant morbidity

(2009) V. Briand et al.   ANNALS OF TROPICAL PAEDIATRICS

Vivax Malaria: A Major Cause of Morbidity in Early Infancy

(2009) Jeanne R. Poespoprodjo et al.   CLINICAL INFECTIOUS DISEASES

The future for blood-stage vaccines against malaria

(2009) Jack S Richards et al.   IMMUNOLOGY AND CELL BIOLOGY

In Vitro Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali

(2009) P. D. Crompton et al.   INFECTION AND IMMUNITY

Acquisition of antibody isotypes againstPlasmodium falciparumblood stage antigens in a birth cohort

(2009) N. O. DUAH et al.   PARASITE IMMUNOLOGY

Placental Malaria Increases Malaria Risk in the First 30 Months of Life

(2008) Norbert G. Schwarz et al.   CLINICAL INFECTIOUS DISEASES

Differences in Human Antibody Reactivity to Plasmodium falciparum Variant Surface Antigens Are Dependent on Age and Malaria Transmission Intensity in Northeastern Tanzania

(2008) L. S. Vestergaard et al.   INFECTION AND IMMUNITY

Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

(2008) F. H. A. Osier et al.   INFECTION AND IMMUNITY

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum

(2008) Muhammad Karyana et al.   MALARIA JOURNAL